AMANDA MARTIN: Open Payments
NPI 1952690588 · TAZEWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 10 payments from 8 companies in 2025. Trend: 2023 $38 · 2024 $433 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| ABBVIE INC. | 1 | $20 |
| Caris MPI, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| BeOne Medicines USA, Inc. | 1 | $15 |
Products named: LYBALVI, NINLARO, NERLYNX, CALQUENCE, VRAYLAR, MI CANCER SEEK, CAPLYTA, TEVIMBRA.
Industry payments across TN — which companies pay providers there.
